Farrer MJ - Search Results

1

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.

Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschländer A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjigeorgiou GM, Hicks AA, Hattori N, Klein C, Jeon B, Kim YJ, Lesage S, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pihlstrøm L, Pramstaller PP, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Silburn PA, Theuns J, Tan EK, Tomiyama H, Toft M, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore DM, Krüger R, Sharma M; GEO-PD Consortium. Wang L, et al. Among authors: farrer mj. Neurology. 2015 Oct 13;85(15):1283-92. doi: 10.1212/WNL.0000000000002016. Epub 2015 Sep 9. Neurology. 2015. PMID: 26354989 Free PMC article.

2

Genetics of Parkinson's disease.

Lynch T, Farrer M, Hutton M, Hardy J. Lynch T, et al. Science. 1997 Nov 14;278(5341):1212-3. Science. 1997. PMID: 9411743 No abstract available.

3

Low frequency of alpha-synuclein mutations in familial Parkinson's disease.

Farrer M, Wavrant-De Vrieze F, Crook R, Boles L, Perez-Tur J, Hardy J, Johnson WG, Steele J, Maraganore D, Gwinn K, Lynch T. Farrer M, et al. Ann Neurol. 1998 Mar;43(3):394-7. doi: 10.1002/ana.410430320. Ann Neurol. 1998. PMID: 9506559

4

No pathogenic mutations in the persyn gene in Parkinson's disease.

Lincoln S, Gwinn-Hardy K, Goudreau J, Chartier-Harlin MC, Baker M, Mouroux V, Richard F, Destée A, Becquet E, Amouyel P, Lynch T, Hardy J, Farrer M. Lincoln S, et al. Neurosci Lett. 1999 Jan 4;259(1):65-6. doi: 10.1016/s0304-3940(98)00901-x. Neurosci Lett. 1999. PMID: 10027558

5

Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.

Maraganore DM, Farrer MJ, Hardy JA, Lincoln SJ, McDonnell SK, Rocca WA. Maraganore DM, et al. Among authors: farrer mj. Neurology. 1999 Nov 10;53(8):1858-60. doi: 10.1212/wnl.53.8.1858. Neurology. 1999. PMID: 10563640

6

Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease.

Maraganore DM, Farrer MJ, Hardy JA, McDonnell SK, Schaid DJ, Rocca WA. Maraganore DM, et al. Among authors: farrer mj. Mov Disord. 2000 Jul;15(4):714-9. doi: 10.1002/1531-8257(200007)15:4<714::aid-mds1018>3.0.co;2-3. Mov Disord. 2000. PMID: 10928584

7

Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family.

Gwinn-Hardy K, Singleton A, O'Suilleabhain P, Boss M, Nicholl D, Adam A, Hussey J, Critchley P, Hardy J, Farrer M. Gwinn-Hardy K, et al. Arch Neurol. 2001 Feb;58(2):296-9. doi: 10.1001/archneur.58.2.296. Arch Neurol. 2001. PMID: 11176969

8

alpha-Synuclein gene haplotypes are associated with Parkinson's disease.

Farrer M, Maraganore DM, Lockhart P, Singleton A, Lesnick TG, de Andrade M, West A, de Silva R, Hardy J, Hernandez D. Farrer M, et al. Hum Mol Genet. 2001 Aug 15;10(17):1847-51. doi: 10.1093/hmg/10.17.1847. Hum Mol Genet. 2001. PMID: 11532993

9

Case-Control study of the extended tau gene haplotype in Parkinson's disease.

Maraganore DM, Hernandez DG, Singleton AB, Farrer MJ, McDonnell SK, Hutton ML, Hardy JA, Rocca WA. Maraganore DM, et al. Among authors: farrer mj. Ann Neurol. 2001 Nov;50(5):658-61. doi: 10.1002/ana.1228. Ann Neurol. 2001. PMID: 11706972

10

Identifying genetic factors in Parkinson disease.

Farrer M, Hardy J, Hutton M, Maraganore D, Tsuboi Y, Wszolek ZK. Farrer M, et al. JAMA. 2002 Feb 13;287(6):715-6. doi: 10.1001/jama.287.6.715-a. JAMA. 2002. PMID: 11851532 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

449 results

Search Page